VOLORIDGE INVESTMENT MANAGEMENT, LLC
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 1556921
JUPITER, FL
Position in SRPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,411,961
-$9,491,056 QoQ
Shares Held
432,535
-50.8% QoQ
Ownership
0.410%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $554,830,833 across 41 Biotechnology names. SRPT ranks #21 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
189,217 | $62,606,228 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
672,858 | $50,524,907 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
368,325 | $35,819,606 | |
| 4 | EXEL |
Exelixis, Inc.
|
787,674 | $33,783,337 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
426,583 | $31,678,053 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,426,834 | $29,892,172 | |
| 7 | BNTX |
BioNTech SE
|
307,864 | $27,362,952 | |
| 8 | ASND |
Ascendis Pharma A/S
|
114,275 | $26,138,120 |
All Filings in SRPT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,411,961 | 432,535 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,903,017 | 878,393 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,219,381 | 1,308,738 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,208,050 | 1,474,155 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $29,186,672 | 457,328 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $4,867,337 | 38,973 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,601,486 | 288,617 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $55,728,516 | 430,469 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,574,783 | 358,548 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,877,014 | 97,979 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,220,326 | 97,977 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $40,550,964 | 294,210 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,845,405 | 160,869 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,273,863 | 65,803 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,423,490 | 18,990 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,557,996 | 135,151 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,086,246 | 145,322 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,745,076 | 181,067 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $26,001,775 | 334,471 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $39,646,606 | 531,955 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $4,688,341 | 29,240 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||